Knocksense: A local content and recommendations platform

{{ subpage.title }}

Second phase trials of indigenous coronavirus vaccine, COVAXIN, begin in Jaipur

The success of the first phase trials and consequent positive feedback by the Indian Council of Medical Research has paved the way for the initiation of phase II trials of the COVAXIN vaccination in Jaipur, on Friday. COVAXIN is India's first indigenous vaccine against the spread of coronavirus, which is being co-produced by the Hyderabad based Bharat Biotech and National Institute of Virology, under the guidance of the ICMR.

Read Now Show less